Media

Presentation & Publications

Subretinal Delivery of Investigational ABBV-RGX-314 as a Gene Therapy for nAMD: First Time Results of a Fellow Eye Bilateral Dosing Study

Arshad M. Khanani, MD, MA, FASRS